Jurgen R. Fischer
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).
Journal: Clinical & experimental metastasis
Published: April 08, 2025
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer.
Journal: Frontiers in oncology
Published: February 21, 2021
Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 10, 2020
De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer.
Journal: Frontiers in oncology
Published: December 10, 2020
Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 07, 2020
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer.
Journal: Therapeutic advances in medical oncology
Published: October 19, 2020
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung).
Journal: Frontiers in pharmacology
Published: September 24, 2020
Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 04, 2020
Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: April 02, 2020
Management of adverse events in immune oncology - Practical aspects of immune-related adverse events during immune oncological treatment
Journal: Deutsche medizinische Wochenschrift (1946)
Published: January 31, 2019
Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer.
Journal: Oncology research and treatment
Published: November 23, 2018
Last Updated: 09/26/2026